Tokyo, Japan

Takuya Yotani

This inventor holds 23 USPTO granted patents and 14 published patent applications and 14 EPO patents, primarily in Biochemical Analysis. Top assignees: Sekisui Medical Co., Ltd., Sekisui Techno Molding Co., Ltd., Arkray, Inc.. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takuya Yotani. Retrieved from https://idiyas.com/inventor/takuya-yotani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 23 

% Patents Active = 87.0

 

Average Co-Inventor Count = 3.5

ph-index = 7

Forward Citations = 118(Granted Patents)


Location History:

  • Kyoto, JP (2016)
  • Tokyo, JP (2014 - 2018)
  • Chuo-ku, JP (2017 - 2019)
  • Ibaraki, JP (2016 - 2020)
  • Ryugasaki, JP (2021)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Haemoglobin Analysis
Tumor Determination
DNA Methylation
Sample Preparation
Prognosis Determination
Liquid Chromatography
Reagent Supply
Flow-Type Analysis
Nucleotide Polymorphisms
Specimen Container
Biochemical Devices
Sample Dilution
23 patents (USPTO):Explore Patents

Title: Innovations by Takuya Yotani: Pioneering Methods in Hemoglobin Analysis and Tumor Determination

Introduction

Takuya Yotani, a prominent inventor based in Tokyo, Japan, has made significant contributions to the fields of medical diagnostics through his innovative inventions. With an impressive portfolio of 23 patents, Yotani's work focuses on advanced techniques for analyzing hemoglobin and determining tumors. His inventions highlight the critical intersection of medical science and technology.

Latest Patents

Among Takuya Yotani's latest contributions is the **Haemoglobin Analysis Method for Detecting Abnormal Haemoglobins and/or Thalassemia Markers**. This groundbreaking method enables the separation and detection of various hemoglobins, including those that are abnormal or indicative of thalassemia, using cation exchange chromatography. Notably, it employs an eluent with a pH of 8.1 or higher and an osmotic pressure of 40 mOsm/kg or less for optimal results.

Another significant patent is the **Tumor Determination Method**, which outlines a comprehensive process for identifying tumors. This method utilizes genomic DNA from tissue or cells of a patient affected by a tumor. It involves several steps, including bisulfite treatment of DNA, PCR amplification of the MLH1 promoter region, and ion exchange chromatography to achieve a detection signal. This procedure culminates in the determination of tumors as derived from patients without Lynch syndrome when certain DNA methylation patterns are observed.

Career Highlights

Takuya Yotani has demonstrated remarkable ingenuity throughout his career, contributing to the field while working at notable companies such as Sekisui Medical Co., Ltd. and Sekisui Techno Molding Co., Ltd. His dedication to advancing medical diagnostics has greatly enhanced the ability to detect and analyze critical health conditions.

Collaborations

In his pursuit of innovation, Yotani has collaborated with distinguished colleagues, including Hiroaki Taira and Takayuki Oka. These partnerships have fostered a dynamic exchange of ideas and expertise, further propelling advancements in medical sciences and diagnostics.

Conclusion

Takuya Yotani stands as a leading figure in the realm of medical inventions, specializing in techniques that enhance the detection and analysis of hemoglobin and tumors. His contributions, underscored by a strong patent portfolio, exemplify the role of innovation in transforming healthcare practices, demonstrating the impact of dedicated inventors on the medical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…